Neurocrine Biosciences
A HEOR leader at Neurocrine Biosciences focused on generating disease- and product-specific evidence to inform commercial strategy, value assessment, and market access. The role partners with Clinical Development, Medical Affairs, and Brand teams and contributes to the development and execution of HEOR strategy while overseeing vendors and HEOR content.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
1992
Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders. With over 30 years of research, the company works to bring hope to people living with rare diseases and conditions that lack viable treatment options. Neurocrine develops and markets approved medicines while maintaining an active clinical pipeline across multiple therapeutic areas.
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
1 day ago
Magnetar Financial LLC Acquires New Holdings in Neurocrine Biosciences, Inc. $NBIX
5 hours ago
Is It Time To Reassess Neurocrine Biosciences (NBIX) After The Recent Share Price Pullback
23 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Neurocrine Biosciences.
Capital Fund Management S.A. Has $17.37 Million Holdings in Neurocrine Biosciences, Inc. $NBIX
7 hours ago
Senior Manager, HEOR - Endocrinology
lifelancer
Director, HEOR
lifelancer
Director, HEVA (HEOR) Business Partner
Sanofi
Vice President, Health Economics and Outcomes Research
Crinetics Pharmaceuticals
Associate Scientific Director, HEOR
lifelancer
Executive Director, Global HEOR - Cell Therapy,
Bristol Myers Squibb